aminoquinuride

This page covers all aminoquinuride drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Matrix metalloproteinase-9, Interstitial collagenase, Botulinum neurotoxin type A.

Targets

Matrix metalloproteinase-9, Interstitial collagenase, Botulinum neurotoxin type A

Phase 2 pipeline (1)

• Surfen · Neuroscience
  Surfen works by blocking the action of an enzyme called interstitial collagenase, which breaks down collagen.

Patent intelligence

• aminoquinuride patent landscape — aggregated cliff calendar, attackable patents, originator estates